2seventy bio, Inc.
TSVT
$4.81
$0.061.26%
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -27.89% | 16.39% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -27.89% | 16.39% | |||
| Cost of Revenue | -59.81% | -10.92% | |||
| Gross Profit | 70.83% | 17.59% | |||
| SG&A Expenses | -22.13% | -21.86% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -52.00% | -13.43% | |||
| Operating Income | 58.16% | 18.75% | |||
| Income Before Tax | 147.23% | 7.30% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 147.23% | 7.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 147.23% | 7.30% | |||
| EBIT | 58.16% | 18.75% | |||
| EBITDA | 59.87% | 18.12% | |||
| EPS Basic | 147.12% | 8.53% | |||
| Normalized Basic EPS | 63.76% | 21.52% | |||
| EPS Diluted | 144.48% | 8.53% | |||
| Normalized Diluted EPS | 65.62% | 21.52% | |||
| Average Basic Shares Outstanding | 0.22% | 1.34% | |||
| Average Diluted Shares Outstanding | 5.65% | 1.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
